These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 25069676)
1. A bone metastases model of anaplastic thyroid carcinoma in athymic nude mice. Zhang L; Wang H; Liang S; Ma C Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):351-6. PubMed ID: 25069676 [TBL] [Abstract][Full Text] [Related]
2. An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice. Kim S; Park YW; Schiff BA; Doan DD; Yazici Y; Jasser SA; Younes M; Mandal M; Bekele BN; Myers JN Clin Cancer Res; 2005 Mar; 11(5):1713-21. PubMed ID: 15755992 [TBL] [Abstract][Full Text] [Related]
3. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Zhou M; Chen Y; Adachi M; Wen X; Erwin B; Mawlawi O; Lai SY; Li C Biomaterials; 2015 Jul; 57():41-9. PubMed ID: 25913249 [TBL] [Abstract][Full Text] [Related]
4. (18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer. Levy A; Leboulleux S; Lepoutre-Lussey C; Baudin E; Ghuzlan AA; Hartl D; Deutsch E; Deandreis D; Lumbroso J; Tao Y; Schlumberger M; Blanchard P Oral Oncol; 2015 Apr; 51(4):370-5. PubMed ID: 25595614 [TBL] [Abstract][Full Text] [Related]
5. Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT. Aoyama M; Takizawa H; Otani T; Inoue S; Kawakita N; Tsuboi M; Bando Y; Uehara H; Kondo K; Tangoku A Oncol Rep; 2020 Oct; 44(4):1709-1716. PubMed ID: 32945510 [TBL] [Abstract][Full Text] [Related]
6. Preparation of human single-chain variable fragment antibodies against anaplastic thyroid carcinoma, and single photon emission‑computed tomography/computed tomography imaging in tumor-bearing nude mice. Liu Q; Pang H; Liu Q; Zhou J; Liu Y Oncol Rep; 2017 May; 37(5):2980-2986. PubMed ID: 28393196 [TBL] [Abstract][Full Text] [Related]
8. (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging. Kang WJ; Song EH; Park JY; Park YJ; Cho A; Song HT Nucl Med Biol; 2015 Sep; 42(9):728-33. PubMed ID: 26068116 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Qiu ZL; Xue YL; Song HJ; Luo QY Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Kasperbauer JL; Reading CC; Hay ID; Lowe VJ Thyroid; 2008 Jul; 18(7):713-9. PubMed ID: 18630999 [TBL] [Abstract][Full Text] [Related]
11. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Grabellus F; Nagarajah J; Bockisch A; Schmid KW; Sheu SY Clin Nucl Med; 2012 Feb; 37(2):121-7. PubMed ID: 22228332 [TBL] [Abstract][Full Text] [Related]
12. Novel esophageal squamous cell carcinoma bone metastatic clone isolated by scintigraphy, X ray and micro PET/CT. Zhao BZ; Cao J; Shao JC; Sun YB; Fan LM; Wu CY; Liang S; Guo BF; Yang G; Xie WH; Yang QC; Yang SF World J Gastroenterol; 2014 Jan; 20(4):1030-7. PubMed ID: 24574775 [TBL] [Abstract][Full Text] [Related]
13. Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer. Li XJ; Gangadaran P; Kalimuthu S; Oh JM; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC Int J Cancer; 2016 Dec; 139(11):2583-92. PubMed ID: 27537102 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive anaplastic thyroid carcinoma: report of a case and literature review. Dibelius G; Mehra S; Clain JB; Urken ML; Wenig BM Thyroid; 2014 Aug; 24(8):1319-24. PubMed ID: 24865498 [TBL] [Abstract][Full Text] [Related]
15. HN1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by interacting with STMN1. Pan Z; Fang Q; Li L; Zhang Y; Xu T; Liu Y; Zheng X; Tan Z; Huang P; Ge M Cancer Lett; 2021 Mar; 501():31-42. PubMed ID: 33359451 [TBL] [Abstract][Full Text] [Related]
16. Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer. Ciarallo A; Marcus C; Taghipour M; Subramaniam RM PET Clin; 2015 Apr; 10(2):265-78. PubMed ID: 25829091 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies. Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571 [TBL] [Abstract][Full Text] [Related]
18. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer. Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243 [TBL] [Abstract][Full Text] [Related]